Identification of the Binding Sites of the SR49059 Nonpeptide Antagonist into the V1a Vasopressin Receptor Using Sulfydryl-reactive Ligands and Cysteine Mutants as Chemical Sensors
Open Access
- 1 October 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (41) , 40010-40019
- https://doi.org/10.1074/jbc.m301128200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Cysteine mutants as chemical sensors for ligand–receptor interactionsTrends in Pharmacological Sciences, 2001
- Functional Architecture of Vasopressin/Oxytocin ReceptorsJournal of Receptors and Signal Transduction, 1999
- Effects of SR 49059, a New Orally Active and Specific Vasopressin V 1 Receptor Antagonist, on Vasopressin-Induced Vasoconstriction in HumansHypertension, 1997
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressinFEBS Letters, 1996
- The Binding Site of Neuropeptide Vasopressin V1a ReceptorJournal of Biological Chemistry, 1995
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.Hypertension, 1994
- Attenuation of spontaneous hypertension in rats by a vasopressin antagonist.Hypertension, 1988
- Vasopressin in Circulatory Control and HypertensionJournal Of Hypertension, 1985